Arbutus Biopharma Corporation
Substituted pyridinone-containing trycyclic compounds, and methods using same

Last updated:

Abstract:

The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.

Status:
Grant
Type:

Utility

Filling date:

3 Nov 2017

Issue date:

3 Nov 2020